Neuroreplacement of Degenerative Cholinergic Cells
About the Research Project
Program
Award Type
Standard
Award Amount
$99,990
Active Dates
April 01, 2004 - February 28, 2007
Grant ID
A2004226
Summary
Cholinergic neurons, which are closely associated with memory function, selectively degenerate in Alzheimer’s disease (AD). Dr. Qu’s previous research has demonstrated that transplanted human neural stem cells (hNSCs) migrate to the proper sites and differentiate into the proper cell types to replace lesioned cholinergic neurons in the brain. Therefore, the transplantation of hNSCs may be a good candidate as a cholinergic cell replacement therapy for AD. Dr. Qu has found that transplanting hNSCs to aged (24-month-old) rats improved behavioral impairment as measured in the Morris water maze. He was also able to show that neurons and glia derived from the transplanted cells were present in several areas of the host brain. Dr. Qu’s behavioral research is now investigating the effects of hNSC transplantation on the cognitive function of brain-lesioned animals using several different types of mazes. It is hoped that this research will provide valuable data to assess the effectiveness of human neural stem cell transplantation as a means to replace degenerative cholinergic neurons in the central nervous system.
Related Grants
Alzheimer's Disease Research
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
Alzheimer's Disease Research
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Alzheimer's Disease Research
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University